Other EU Funding

Besides Horizon 2020 and Horizon Europe there are many other relevant funding programmes managed by several agencies and directorates of the European Commission.

All EU funding, now collected in one convenient place

The EU provides funding for a wide range of projects and programs, covering almost all areas. Finding your way in this vast landscape of possibilities is not always easy and can be very time consuming. But no longer...

Flanders Innovation & Entrepreneurship (VLAIO) has created the handy EU Funding Overview tool . Find your way faster within the EU jungle of support options. Check what funding is available to finance your projects, company or organisation.

List of Flemish contact points

Found a funding programme that fits your needs, but don't know who can help you out?

Consult VLEVA's list of contact points in Flanders for European programmes, other than Horizon 2020 and Horizon Europe.

Below you can find a handpicked selection of European funding programmes. We listed those that are closely related to Horizon 2020 and Horizon Europe, so expect mostly Research, Development & Innovation programmes in thematics related to the Horizon domains.

AAL (Active Assisted Living)

AAL (Active Assisted Living) is a European Joint Program that supports projects that increase the quality of life of older people through the use of ICT.

Alain Thielemans

| +32 2 432 42 44

ERA-NET by FWO

ERA-NET (European Research Area Networks) is the policy instrument of the European Commission for the coordination of national research programmes in Europe. FWO uses this instrument to enable and encourage researchers in Flanders to cooperate with their colleagues in other countries.

Dr. Olivier Boehme

| +32 2 550 15 45

ERA-NET by VLAIO

ERA-NET (European Research Area Networks) is the policy instrument of the European Commission for the coordination of national research programmes in Europe. VLAIO uses this instrument to enable and encourage companies (SMEs and large enterprises) in Flanders to cooperate with their colleagues in other countries

VLAIO Infolijn

| 0800 20 555

ERDF-INTERREG

Together with the ERDF Flanders program, Interreg programs form the ERDF part of the cohesion policy in Flanders.

Jorre Van Damme

| +32 2 553 37 70

EUREKA

The European cooperation program EUREKA provides a label to companies for the implementation of applied market-oriented industrial research and development.

Lieve Apers

| + 32 2 212 94 21

Eurostars

EUROSTARS, set up by Eureka, focuses on research-intensive SMEs, and is based on the 'bottom-up' principle: EUROSTARS puts the SMEs at the wheel, supports small consortia, and stimulates market-oriented projects in themes that the SMEs themselves determine.

Frederik De Vusser

| +32 2 432 42 98

Innovation Fund

The Innovation Fund was set up with the revenues of the emission trading system (ETS). The purpose is to reduce greenhouse gas emissions by private companies in harder to abate sectors. It aims at 4 technologies: renewable energy sources and storage, carbon capture and storage, carbon capture and utilization, innovative low carbon solutions.

Michiel Maertens

Life +

Is the EU’s financial instrument supporting environmental, nature conservation and climate action projects throughout the EU.

VEKA

Testimonial

Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.

Read the full article or Check out the other testimonials

Funding programmes

Content

Tools